Atención farmacéutica a paciente con diabetes mellitus tipo ii, administrando metformina como fármaco de primera elección.

Abstract

Type II Diabetes Mellitus is considered a degenerative disease, which worldwide has claimed countless lives to this day. It is represented as a metabolic disorder, in which glucose levels are high, brings with it complications such as retinopathy, nephropathy, cardiovascular and cerebrovascular disorders, neuropathies, and amputations, this disease is related to obesity and poor eating habits. People with a diagnosis of DM2 in most cases do not properly control blood sugar levels, fail drug treatment, and lead a disorderly lifestyle. Pharmaceutical care is one of the many activities carried out by a Biochemical Pharmacist and is aimed at achieving an appropriate pharmacological therapy that promotes the improvement of the patient’s quality of life. The general objective of this case study is: To develop a pharmaceutical care program for Type II Diabetes Mellitus patient, non-insulin-dependent, by detecting drug-related problems, lifestyle and pharmacotherapeutic control, to counteract the complications of the disease. The methodology used is descriptive and analytical in order to fully meet the objectives set, for which a bibliographical investigation of current scientific articles was carried out that provide us with the complete information for the resolution of the problem case. Conclusion: The risk factors and problems related to the drug (metformin) were identified, which allowed the development of a care plan for patients with DM2.